Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line.
about
Marine natural products as breast cancer resistance protein inhibitorsThe FLT3 inhibitor quizartinib inhibits ABCG2 at pharmacologically relevant concentrations, with implications for both chemosensitization and adverse drug interactionsKinetic Modeling of ABCG2 Transporter Heterogeneity: A Quantitative, Single-Cell Analysis of the Side Population Assay.Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.Monitoring a nuclear factor-κB signature of drug resistance in multiple myeloma.ABCG2 expression, function, and promoter methylation in human multiple myelomaRole of the breast cancer resistance protein (ABCG2) in drug transport.IMP3 protein promotes chemoresistance in breast cancer cells by regulating breast cancer resistance protein (ABCG2) expression.Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu.The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2TrAp: a tree approach for fingerprinting subclonal tumor composition.The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanismsA Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001.A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport.Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation.A theoretical quantitative model for evolution of cancer chemotherapy resistanceEstablishment and characterization of 6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103)-resistant cell lines.Increased expression of the tight junction protein TJP1/ZO-1 is associated with upregulation of TAZ-TEAD activity and an adult tissue stem cell signature in carfilzomib-resistant multiple myeloma cells and high-risk multiple myeloma patients.Improving adenoviral vectors and strategies for prostate cancer gene therapy
P2860
Q27027706-3D978049-812D-42BB-92A6-4240143165ACQ28535342-A1D2191A-524B-422D-AF00-9C25D7CDDAEBQ32186144-4D6422FC-17EB-4117-BEE5-9F1C0F29464CQ34871636-BCAC58AC-0324-4843-9EC7-6D04C608F813Q35579598-A26A4B08-A94A-4C71-A9CF-096A5451A967Q35848835-4984A4F6-411B-4C29-92E7-B2766083A058Q36250753-9378A1C5-C571-48E7-988A-45D98A10947CQ36812342-95A1AEB0-9139-468F-BED1-7D0259474E22Q36835070-88EA0A75-F9AC-421A-97D1-1CAB83F55F09Q36933169-23F0B92D-FEDB-4A4F-8CB1-6F94E2258CC6Q37197845-9E5B1F79-CD18-4B74-AE43-5E60C09507B8Q37289700-8D91607F-E5A0-44F5-B8AE-0DF3F1A7EDCAQ37397624-D099B694-CE87-478C-A208-941931126028Q38354761-3E31245B-3845-41B9-9F0D-1586C8459ED3Q38796029-DD42871A-5A6A-4288-BD41-B43575D8624CQ40516956-C904F46F-1122-489E-8CC6-2132D1506C7CQ40876344-3B6462EF-43A4-4CB5-A3FA-8462C6585851Q42022337-529CB302-A9C5-4297-93BD-34AB4DC9519CQ58801177-9478C4F2-B01D-4E66-8AC2-EBFC17233A3F
P2860
Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Multiple mechanisms confer dru ...... human 8226 myeloma cell line.
@en
type
label
Multiple mechanisms confer dru ...... human 8226 myeloma cell line.
@en
prefLabel
Multiple mechanisms confer dru ...... human 8226 myeloma cell line.
@en
P2093
P4510
P1433
P1476
Multiple mechanisms confer dru ...... e human 8226 myeloma cell line
@en
P2093
De Jong MC
Gleason-Guzman MC
Greenberger LW
Hazlehurst LA
P304
P407
P50
P577
1999-03-01T00:00:00Z